RheumatologyRHEUMATOLOGY

3D render of a blue medical image of close up of knee joint

3 Sites on 30 SubjectsRheumatoid Arthritis Biosimilar Phase IV

A Phase IV. Longitudinal, prospective, open clinical trial to evaluate the safety, efficacy, and quality of health with Etanercept treatment as a complementary therapy with inadequate response to disease modifier drugs in patients with active rheumatoid arthritis. LAFRANCOL/RECALCINE/ABBOT 2012-2015
Protocol Design
Start-up
Regulatory Affairs
Clinical Operations

6 Sites on 79 SubjectsRheumatoid Arthritis Novel Biologic Phase IV

WA25204 ( ENTRACTE ). A clinical outcomes studies to evaluate the effects of two biologic treatments ( TCZ and Etanercept ) on the rate of CV events in patients with moderate to severe rheumatoid arthritis. ROCHE 2011-2016
Subcontracted by Quintiles (IQVIA) Responsible person for Regulatory Approval and follow up
Sports young woman
open chat
need help?
Hi, how can we help you?